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Abstract Liver parenchymal cells play a dominant role in
hepatic metabolism and thereby total body cholesterol ho-
meostasis. To gain insight into the specific pathways and
genes involved in the response of liver parenchymal cells to
increased dietary lipid levels under atherogenic conditions,
changes in parenchymal cell gene expression upon feeding a
Western-type diet for 0, 2, 4, and 6 weeks were determined
using microarray analysis in LDL receptor-deficient mice, an
established atherosclerotic animal model. Using ABI Mouse
Genome Survey Arrays, we were able to detect 7,507 genes
(28% of the total number on an array) that were expressed
in parenchymal cells isolated from livers of LDL receptor-
deficient mice at every time point investigated. Time-
dependent gene expression profiling identified fatty acid
binding protein 5 (FABP5) and four novel FABP5-like tran-
scripts located on chromosomes 2, 8, and 18 as important
proteins in the primary response of liver parenchymal cells
to Western-type diet feeding, because their expression was
16- to 22-fold increased within the first 2 weeks on theWestern-
type diet. The rapid substantial increase in gene expression
suggests that these FABPs may play an important role in the
primary protection against the cellular toxicity of cholesterol,
free fatty acids, and/or lipid oxidants. Furthermore, as a sec-
ondary response to the Western-type diet, liver parenchymal
cells of LDL receptor-deficient mice stimulated glycolysis
and lipogenesis pathways, resulting in a steady, more athero-
genic serum lipoprotein profile (increased VLDL/LDL).—
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High levels of circulating cholesterol attributable to the
consumption of Western-type/high-fat diets form a major
risk factor for atherosclerosis and subsequent cardiovas-
culardiseases (e.g.,myocardial infarction, stroke)(1),which
are the leading causes of death in theWesternworld. Several
mutations in the LDL receptor are associated with familial
hypercholesterolemia, a dominantly inherited error of
metabolism characterized by increased plasma LDL levels,
xanthomas of skin and tendons, and premature heart dis-
ease caused by atherosclerosis of the coronary arteries (2).
The liver is an essential organ in the regulation of serum
cholesterol levels because it is able to clear excess choles-
terol from the blood for subsequent excretion into the bile
(3, 4). In addition, the liver is responsible for the synthesis
and secretion of VLDL and HDL, respectively (5, 6). Be-
cause of the important role of the liver in the control of
serum cholesterol levels, several studies have recently been
conducted using microarray technology to determine the
molecular mechanisms underlying long-term high-fat diet-
induced alterations in total mouse liver (7–9). However,
a common problem with these types of microarray studies
is the heterogeneity of the liver, which contains several
different cell types, each of which has its specific localiza-
tion and function. Kupffer cells are tissue macrophages
strategically located within the liver sinusoids, and their
function is the removal of bacteria and the clearance of
modified lipoproteins. Hepatic endothelial cells line the
sinusoids, where they function in the removal of modified
lipoproteins and mediate their natural barrier function.
However, the majority of liver cells are parenchymal cells
(z60%), which are located between bile canaliculi and
sinusoids, where they mediate both the uptake and metab-
olism of cholesterol for biliary excretion and the synthesis
and secretion of VLDL and HDL.
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Importantly, in earlier studies, we showed that not only
the function of parenchymal cells is different from that of
other hepatic cells but also the expression and regulation
of genes involved in lipid metabolism are markedly dif-
ferent between the different hepatic cell types (10, 11).
Furthermore, earlier studies by Recinos et al. (12) using
microarray analysis of total liver RNA have indicated that
feeding mice a high-fat diet results in significant changes
in the expression of hepatic genes involved in cholesterol
metabolism as well as in the expression of CD68 and CD63.
The latter two proteins are expressed in Kupffer and
stellate cells (13, 14) but not in parenchymal cells, which
together with our findings (10, 11) suggests that it is dif-
ficult to interpret data from microarray studies that are
based on total liver mRNA. Therefore, in this study,
using microarray technology, we focused on the specific
response of liver parenchymal cells to atherogenic diet
feeding in LDL receptor-deficient mice, an established
atherosclerosis mouse model.
MATERIALS AND METHODS
Animals
Homozygous LDL receptor-deficient mice (15, 16) were ob-
tained from the Jackson Laboratory as mating pairs and bred at
the Gorlaeus Laboratories. Female mice were maintained on
sterilized regular chow containing 4.3% (w/w) fat and no cho-
lesterol (RM3; Special Diet Services, Witham, UK) or were fed a
semisynthetic Western-type diet containing 15% (w/w) cacao
butter and 0.25% (w/w) cholesterol (Diet W; Special Diet Ser-
vices) for 2, 4, or 6 weeks. Subsequently, parenchymal liver cells
were isolated essentially according to the method of Nagelkerke,
Barto, and Van Berkel (17) as modified for mice by Van Berkel
et al. (18). The purity and viability of the cells were analyzed using
trypan blue staining and phase-contrast microscopy. Western-
type diet feeding had no effect on the viability or purity of the
isolated cells; the liver parenchymal cell fractions consisted of
.99% parenchymal cells with a viability of .95% under both
standard and Western-type diet feeding conditions.
Serum lipid analyses
Serum concentrations of free and total cholesterol were
determined using enzymatic colorimetric assays (Roche Diag-
nostics). The cholesterol distribution over the different lipo-
proteins in serum was analyzed by fractionation of 30 ml of serum
from each mouse using a Superose 6 column (3.2 3 30 mm,
Smart-system; Pharmacia). Total cholesterol content of the
effluent was determined using enzymatic colorimetric assays
(Roche Diagnostics).
Microarray analysis
Total RNA from liver parenchymal cells was isolated according
to Chomczynski and Sacchi (19). Double-stranded cDNA was
prepared from total RNA. An in vitro transcription reaction was
used to synthesize UTP-digoxigenin-labeled complementary
RNA (cRNA). Equal amounts of cRNA from two pooled RNA
samples of two mice (total of four mice) per time point were
hybridized to ABI Mouse Genome Survey Arrays (Applied
Biosystems) according to the manufacturer’s instructions. The
ABI Mouse Genome Survey Arrays used in the study contained
33,012 different probes representing 26,514 genes, which
included transcripts from the public domain as well as from the
Celera library. Subsequently, an alkalic phosphatase-linked di-
goxigenin antibody was incubated with the array, and the phos-
phatase activity was initiated to start the chemiluminescent signal.
The chemiluminescent (cRNA) and fluorescent (spot back-
ground) signals of the cRNA and standard control spots were
scanned for 5 and 25 s using an AB1700 Chemiluminescence
Analyzer (Applied Biosystems). Using the software supplied with
the AB1700 apparatus, the spot chemiluminescent signal was
normalized over the fluorescent signal of the same spot (using
the standard control signals) to obtain the normalized signal
value that was used for further analysis. In addition, a signal-
to-noise ratio for every spot was obtained, which needed to be at
least 1 at each time point (.90% spot confidence) to use the spot
for further analysis. In the analysis, the median value of the
normalized signal of two independent arrays for each time point
was calculated as an indication of the relative gene expression
number at that time point. To identify genes that are regulated in
a similar manner upon Western-type diet feeding, K-means clus-
tering was performed on gene expression profiles (relative ex-
pression compared with the chow diet) derived from the primary
microarray analysis. In detail, for the K-means clustering initiali-
zation, a data centroid-based search was used with a maximum of
five clusters, whereas similarity between gene expression profiles
was determined using a cosine correlation (Spotfire software).
Confirmation of gene expression changes by real-time
quantitative PCR
Quantitative gene expression analysis of isolated liver paren-
chymal cells was performed as described (10). In short, total RNA
TABLE 1. Primers used for real-time quantitative PCR
Gene
GenBank
Accession
Number Forward Primer Reverse Primer
Amplicon
Size
Acidic ribosomal phosphoprotein P0 NM007475 GGACCCGAGAAGACCTCCTT GCACATCACTCAGAATTTCAATGG 85
Acetyl-CoA carboxylase XM109883 AGAATCTCCTGGTGACAATGCTTATT GCTCTGTGAGGATATTTAGCAGCTC 87
ATP-citrate lyase NM134037 AGGTACCCTGGGTCCACATTC CTACGATCATCTTGACTCCTGGAGT 73
Fatty acid binding protein 5 BC002008 GGAAGGAGAGCACGATAACAAGA GGTGGCATTGTTCATGACACA 73
Glyceraldehyde-3-phosphate
dehydrogenase
NM008084 TCCATGACAACTTTGGCATTG TCACGCCACAGCTTTCCA 103
Hypoxanthine guanine phosphoribosyl
transferase
J00423 TTGCTCGAGATGTCATGAAGGA AGCAGGTCAGCAAAGAACTTATAG 91
Malic enzyme NM008615 TTAAGGATCCACTGTACATCGGG GGCGTCATACTCAGGGCCT 62
Liver pyruvate kinase NM013631 AAGACAGTGTGGGTGGACTACCA CGTCAATGTAGATGCGGCC 70
Sterol-regulatory element binding
protein-1
AB017337 GACCTGGTGGTGGGCACTGA AAGCGGATGTAGTCGATGGC 74
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was isolated according to Chomczynski and Sacchi (19) and
reverse-transcribed using RevertAidTM reverse transcriptase. Gene
expression analysis was performed using real-time SYBR Green
technology (Eurogentec) with the primers listed in Table 1.
Hypoxanthine guanine phosphoribosyl transferase (HPRT),
GAPDH, and acidic ribosomal phosphoprotein P0 (36B4) were
used as the standard housekeeping genes. Relative gene
expression numbers were calculated by subtracting the threshold
cycle number (Ct) of the target gene from the average Ct of
HPRT, GAPDH, and 36B4 (Cthousekeeping) and raising 2 to the
power of this difference. The average Ct of three housekeeping
genes was used to exclude the possibility that changes in relative
expression were caused by variations in the expression of
separate housekeeping genes.
Immunoblotting
Pelleted liver parenchymal cells were suspended in 500 ml of
lysis buffer (10 mM HEPES, 1.5 mM MgCl2, 10 mM KCl, and
0.5 mM DDT) in the presence of protease inhibitors (0.02 mg/ml
leupeptin, 0.02 mg/ml aprotinin, and 0.02 mg/ml trypsin
inhibitor) and allowed to stand for 20 min on ice. Nuclei were
Fig. 1. A: Effect of a Western-type diet (WTD) on serum-free (open squares) and total (closed squares)
cholesterol levels in LDL receptor-deficient mice. B: Effect of a Western-type diet on serum cholesterol
distribution in LDL receptor-deficient mice. Blood samples were drawn on a chow diet (open circles) and 2
weeks on a Western-type diet (closed circles). Sera from individual mice were loaded onto a Superose 6
column, and fractions were collected. Fractions 3–7 represent VLDL, fractions 8–15 represent LDL, and
fractions 15–19 represent HDL. Error bars represent means 6 SEM (n 5 4) per group.
Fig. 2. Gene clusters detected in liver parenchymal cells of LDL receptor-deficient mice. K-means clus-
tering of genes was performed based upon similarity in their regulation profiles upon Western-type diet
(WTD) feeding.
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pelleted by a 10 min centrifugation (13,000 rpm) at 48C. The
pelleted nuclei were resuspended in a hypertonic buffer [20 mM
HEPES, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and 25%
(v/v) glycerol] in the presence of protease inhibitors. Nuclei
were incubated for 10 min at 48C, and a clear nuclear extract was
obtained by centrifugation at 13,000 rpm for 10 min at 48C.
Subsequently, equal amounts of cytoplasmic and nuclear protein
(50 mg) were separated on 7.5% SDS-PAGE gels and electro-
phoretically transferred to Protran nitrocellulose membranes
(Schleicher and Schuell). Immunolabeling was performed using
either goat polyclonal fatty acid binding protein 5 (FABP5; R&D
Systems) or rabbit polyclonal sterol-regulatory element binding
protein-1 (SREBP-1) (H160; Santa Cruz Biotechnology) as pri-
mary antibody and donkey anti-goat IgG or goat anti-rabbit IgG
( Jackson ImmunoResearch), respectively, as secondary antibody.
Finally, immunolabeling was detected by enhanced chemilumi-
nescence (Amersham Biosciences). Changes in protein expres-
sion levels were quantified using ImageQuant software.
RESULTS
Serum lipid levels
Feeding LDL receptor-deficient mice, an established
mouse model for atherosclerosis (15, 16), a Western-type
(atherogenic) diet containing 0.25% cholesterol and 15%
fat resulted in a significant increase in free and total serum
cholesterol levels compared with animals on a regular
chow diet containing 4.3% fat and no cholesterol (Fig. 1A).
In agreement with previous atherosclerosis studies using
the same diet (20, 21), the Western-type diet induced an
atherogenic lipoprotein profile in LDL receptor-deficient
mice, because the circulating serum cholesterol levels of
both LDL and VLDL were markedly induced upon feed-
ing the Western-type diet compared with the chow diet
(Fig. 1B). The dramatic increase in serum VLDL choles-
terol levels upon Western-type diet feeding suggests that
the liver responds to the increase in dietary lipid by stim-
ulating VLDL secretion, whereas the clearance is greatly
inhibited by the absence of the LDL receptor.
Gene expression profiles of liver parenchymal cells
To gain insight into the primary and possible secondary
response of liver parenchymal cells to an increase in
dietary lipids, time-dependent changes in gene expression
upon Western-type diet feeding were investigated using
large-scale gene expression (microarray) analysis. RNA was
isolated from liver parenchymal cells (.99% pure) of LDL
receptor-deficient mice on the regular chow or Western-
type diet (2, 4, or 6 weeks). Two RNA samples containing
TABLE 2. List of genes involved in the primary response of liver parenchymal cells and whose expression was .5-fold changed
after 2 weeks of Western-type diet feeding
Fold Change on Western-Type
Diet Compared with Chow Diet
Celera Gene
Identifier
GenBank Accession
Number 2 Weeks 4 Weeks 6 Weeks Gene
mCG1638 NM010634 22 5.9 5.5 Fatty acid binding protein 5, epidermal (FABP5)
mCG22278 AC134443 19 7.4 7.7 Unassigned FABP, chromosome 8
mCG5289 AC130218 17 10 12 Unassigned FABP, chromosome 18
mCG22653 AC147992 16 11 11 Unassigned FABP, chromosome 18
mCG7050 NM009381 16 8.1 6.9 Thyroid hormone-responsive SPOT14 homolog (THRSP)
mCG9729 AL954662 14 9.2 7.2 Unassigned FABP, chromosome 2
mCG11295 NM029083 9.1 7.7 1.7 DNA damage-inducible transcript 4 (DDIT4)
mCG125511 NM130450 8.6 3.4 3.9 ELOVL family member 6, elongation of long-chain fatty
acids (ELOVL6)
mCG3541 AK076301 8.6 5.9 4.8 Acetyl-CoA carboxylase b
mCG141310 —a 5.5 4.4 5.0 Unassigned acetyl-CoA carboxylase, chromosome 11
mCG2138 NM007988 5.3 2.3 2.1 Fatty acid synthase (FASN)
mCG141659 AK044017 5.3 2.8 2.0 Acetoacetyl-CoA synthetase (AACS)
mCG4614 NM011135 5.2 0.7 2.7 CCR4-NOT transcription complex, subunit 7 (CNOT7)
mCG1036474 AC153894 5.0 2.5 3.1 Unassigned AIG1, chromosome 6
a Unassigned Celera transcript is 99% homologous to AY451393 (acetyl-CoA carboxylase 1).
Fig. 3. Biological process classes with a significantly (P , 0.05;
binomial test; PANTHER software) enhanced number of highly
regulated genes associated with the primary response of liver
parenchymal cells to increased dietary lipid levels.
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pooled RNA from two separate mice per group (total
group size, four mice) were transformed into digoxigenin-
labeled cRNAs, which were simultaneously hybridized to
Applied Biosystems Mouse Genome Survey Arrays (33,012
different probes representing 26,514 genes) for subse-
quent gene expression profiling using AB1700 software.
Using a cutoff minimal signal-to-noise ratio of 1 (.90%
spot confidence) for every time point, we were able to de-
tect 7,507 genes (28% of the total number on an array) that
were expressed in parenchymal cells isolated from livers of
LDL receptor-deficient mice at every time point investi-
gated. Subsequently, using K-means clustering, five groups
of genes were identified that are regulated in a similar
manner upon feeding the diet enriched in cholesterol and
fat (Fig. 2).Gene clusters 1 (n51,305), 2 (n52,110), and3
(n 5 2,408) contain z78% of the total number of genes
detected in liver parenchymal cells. Gene cluster 1 contains
some genes whose expression was .5-fold downregulated
after 6 weeks of Western-type diet feeding (for a more de-
tailed view of cluster 1, see the supplementary Figure I and
Table I). However, in general, the expression of the genes
in clusters 1–3 does not appear to be highly affected upon
Western-type diet feeding at any time point studied, which
suggests a minor role for these gene clusters in the re-
sponse to increased dietary lipid levels. In contrast, gene
cluster 4 (n 5 954) contains genes whose expression is
highly (up to 22-fold) upregulated within the first 2 weeks
of diet feeding, after which the gene expression rapidly
declines even sometimes to the basal level, indicating that
these genes play an important role in the primary response
of liver parenchymal cells to an increase in dietary lipid
levels. Furthermore, the genes in gene cluster 5 (n 5 730)
appear to be involved in the secondary steady response of
liver parenchymal cells to Western-type diet feeding, be-
cause their expression gradually but steadily increases over
time upon Western-type diet feeding for 6 weeks.
Identification of genes and biological processes involved
in the primary response of liver parenchymal cells to
increased dietary lipid levels
All genes on the microarray chips were classified using
the PANTHER classification system, which is a database
that classifies genes into families and subfamilies of shared
function, which are then categorized by molecular func-
tion, biological process, and pathway. As mentioned
above, the 954 genes located in gene cluster 4 appear to
be involved in the primary response of liver parenchymal
cells to the increase in dietary lipid levels, because their
expression is highly increased within the first 2 weeks and
returns for most genes to almost basal levels after 4–6
weeks of Western-type diet feeding. Table 2 summarizes
the list of genes whose expression is stimulated .5-fold
within the first 2 weeks of Western-type diet feeding. The
known/assigned genes in this list include FABP5, thyroid
hormone-responsive SPOT14 homolog (THRSP), DNA
damage-inducible transcript 4 (DDIT4), fatty acid elon-
Fig. 4. A: Time-dependent effect of a Western-type diet (WTD) on parenchymal liver cell gene expression
of fatty acid binding protein 5 (FABP5) and four putative novel FABPs located on chromosomes 2
(mCG9729), 8 (mCG22278), and 18 (mCG5289 and mCG22653), as determined by microarray analysis.
Values are expressed as fold induction on the Western-type diet compared with the regular chow diet
(0 weeks). B: Alignment of the protein amino acid sequences of FABP5 and the four putative novel FABPs. C:
Homology tree of the protein sequences of FABP5 and the four putative novel FABPs. Numbers indicate the
fraction homology between the different FABP sequences.
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gase 6 (ELOVL6), acetyl-CoA carboxylase, fatty acid synth-
ase (Fasn), acetoacetyl-CoA synthetase, and CCR4-NOT
transcription complex, subunit 7 (CNOT7). To identify
significantly affected biological processes that may play
an essential role in the primary response to increased di-
etary lipid levels, the highly (.5-fold) regulated gene list
(Table 2) was compared with the total list of genes
detected in liver parenchymal cells using PANTHER.
Figure 3 clearly shows that, in general, processes dealing
with lipid, fatty acid, and steroid transport and metabolism
are markedly stimulated on the Western-type diet in liver
parenchymal cells of LDL receptor-deficient mice. More
specifically, the biological process classes lipid and fatty
acid binding, steroid hormone-mediated signaling, and
vitamin/cofactor transport are extremely (.100-fold)
overrepresented compared with expected. Strikingly, the
five genes affected in these three classes are FABP5 and
four unassigned putative novel FABPs located on chromo-
somes 2 (mCG9729), 8 (mCG22278), and 18 (mCG5289
and mCG22653), of which the expression was 16- to 19-
fold increased within the first 2 weeks of Western-type diet
feeding. Interestingly, in addition to a similar regulation
profile, these putative FABPs share high sequence homol-
ogy with FABP5 (Fig. 4), suggesting that these four pro-
teins may have a function comparable to FABP5. Recent
evidence has indicated that (intra)cellular lipid binding
proteins, such as FABPs, play a central role in cellular lipid
uptake and metabolism [reviewed by Glatz et al. (22) and
Boord, Fazio, and Linton (23)]. Combined, these findings
suggest that liver parenchymal cells induce the expression
of FABP5 and the four novel FABPs, thereby potentially
facilitating lipid uptake, transport, and metabolism as a
primary response to an increase in dietary lipid levels.
Identification of genes and biological processes involved
in the secondary response of liver parenchymal cells to
increased dietary lipid levels
In contrast to gene cluster 4, the parenchymal liver cell
expression of the 730 genes in gene cluster 5 gradually
increases over time upon feeding LDL receptor-deficient
mice the diet enriched in cholesterol. Therefore, it is as-
sumed that the genes in gene cluster 5 are involved in the
secondary response of liver parenchymal cells to increased
dietary lipid levels. Further investigation into the genes in
gene cluster 5 showed that, among others, the expression
of glucosidase b2 (GBA2), stearoyl-CoA desaturase 1, and
serine/arginine-rich protein-specific kinase 2 (SRPK2) was
markedly (.5-fold) stimulated after 6 weeks of Western-
type diet feeding (Table 3). In addition, biological process
identification using the .5-fold-regulated gene list in
PANTHER revealed that the tricarboxylic acid pathway was
40-fold overexpressed compared with the expected frac-
tion after 6 weeks of Western-type diet, with less prominent
inductions (8- to 20-fold) in carbohydrate, coenzyme, and
prosthetic group metabolism (Fig. 5). The genes in the
tricarboxylic acid and carbohydrate, coenzyme, and pros-
thetic group metabolism pathways of which the expression
was .5-fold changed upon feeding the Western-type for
TABLE 3. List of genes involved in the secondary response of liver parenchymal cells and whose expression was .5-fold changed after 6 weeks of
Western-type diet feeding
Fold Change on Western-Type
Diet Compared with Chow Diet
Celera Gene
Identifier
GenBank Accession
Number 2 Weeks 4 Weeks 6 Weeks Gene
mCG19285 NM172692 0.9 0.4 14 Glucosidase b2 (GBA2)
mCG11623 NM009139 1.8 3.9 14 Chemokine (C-C motif) ligand 6 (CCL6)
mCG131749 NM009127 7.4 8.1 11 Stearoyl-CoA desaturase 1 (SCD1)
mCG4527 NM009274 1.3 1.3 10 Serine/arginine-rich protein-specific kinase 2 (SRPK2)
mCG117361 N.F.a 1.2 0.7 9.8 Unassigned high-mobility group protein, chromosome 2
mCG21064 NM019811 5.9 6.7 8.6 Acyl-CoA synthetase short-chain family member 2 (ACSS2)
mCG3047 NM013590 1.2 2.4 8.3 P lysozyme structural (LZP-S)
mCG17532 NM011125 4.0 6.1 8.0 Phospholipid transfer protein (PLTP)
mCG1045095 AC115121 5.1 4.3 7.2 Unassigned olfactory receptor, chromosome 19
mCG11880 XM001004685 7.3 5.5 6.8 Unassigned malic enzyme, chromosome 9
mCG18119 NM008149 6.7 7.2 6.6 Glycerol-3-phosphate acyltransferase, mitochondrial (GPAM)
mCG20527 NM134037 6.0 7.4 6.5 ATP-citrate lyase (ACLY)
mCG133578 NM016751 1.5 2.3 6.5 C-type lectin domain family 4, member f (CLEC4F)
mCG6775 NM008035 1.8 2.2 6.3 Folate receptor 2 (fetal) (FOLR2)
mCG119533 NM013532 2.1 2.0 6.2 Leukocyte immunoglobulin-like receptor, subfamily B, member 4 (LILRB4)
mCG1028439 AK007376 3.5 5.2 6.2 RIKEN cDNA 1810008I18 gene (1810008I18RIK)
mCG21218 NM008062 4.8 4.8 5.9 Glucose-6-phosphate dehydrogenase X-linked (G6PDX)
mCG17567 NM013631 5.5 4.6 5.8 Pyruvate kinase liver and red blood cell (PKLR)
mCG3791 NM023121 1.4 2.1 5.6 Guanine nucleotide binding protein (G protein), g-transducing activity
polypeptide 2 (GNGT2)
mCG129478 AL831708 1.1 1.8 5.5 Unassigned, chromosome U
mCG117710 X12905 1.5 2.6 5.5 Properdin factor, complement (PFC)
mCG9333 NM009777 1.2 1.8 5.4 Complement component 1, q subcomponent, b polypeptide (C1QB)
mCG117848 NM028717 2.4 1.8 5.4 Amyotrophic lateral sclerosis 2 (juvenile) homolog (ALS2)
mCG3081 NM009690 1.8 2.3 5.3 CD5 antigen-like (CD5L)
mCG6766 NM010531 2.0 2.9 5.2 Interleukin 18 binding protein (IL18BP)
mCG12963 NM013706 1.4 1.6 5.0 CD52 antigen (CD52)
a N.F., no homologous GenBank accession number found for the given unassigned Celera transcript sequence.
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6 weeks include ATP-citrate lyase (ACLY; 6.5-fold), liver
pyruvate kinase (PKLR; 5.8-fold), glucose-6-phosphate
dehydrogenase X-linked (G6PDX; 5.9-fold), acyl-CoA syn-
thetase short-chain family member 2 (8.6-fold), and an
unassigned transcript coding for malic enzyme (6.8-fold).
ACLY, PKLR, G6PDX, and malic enzyme are key enzymes
involved in endogenous cholesterol, fatty acid, triacylglyc-
erol, and phospholipid synthesis (lipogenesis) in the liver
(24). Interestingly, SREBPs are a family of transcription
factors involved in lipogenesis, as they can regulate the
gene expression of lipogenic enzymes (25). Interestingly,
the gene expression of SREBP-1 was increased z2-fold
upon Western-type diet feeding.
Confirmation of changes in gene expression by real-time
quantitative PCR
Representative genes with the different responses were
selected for validation using real-time quantitative PCR.
Time-dependent regulation of the expression of genes in-
volved in the primary response (i.e., FABP5 and acetyl-CoA
carboxylase) and secondary response (i.e., pyruvate kinase,
ACLY, malic enzyme, and SREBP-1) of liver parenchymal
cells to Western-type diet feeding could be confirmed by
real-time quantitative PCR usingHPRT, 36B4, andGAPDH
as housekeeping gene controls (Fig. 6; for Ct values and
absolute mRNA expression levels, see supplementary
Table II). FABP5 mRNA expression is readily detectable
under normal feeding conditions [Ct 5 23.07; the no-RT
control Ct value is 38 (data not shown)], and it is markedly
enhanced upon Western-type diet feeding (Ct values of
18.91, 18.76, and 18.72 after 2, 4, and 6weeks, respectively).
FABP5 thus seems to play a very important role in the
primary response; therefore, it was determined whether
Western-type diet-induced changes in gene expression
levels of FABP5 were translated into similar changes at the
protein level. FABP5 protein expression was undetectable
under both chow and Western-type diet feeding condi-
tions, indicating that the protein expression level of FABP5
is low in parenchymal cells. This is in agreement with our
original microarray data, which show that the gene ex-
pression of FABP5 and the four putative novel FABPs is
relatively low [relative expression levels of 9.3 (FABP5),
50.3 (mCG22278), 13.5 (mCG5289), 19.0 (mCG22653),
and 9.6 (mCG9729), respectively] compared with, for in-
stance, the expression of FABP1/L-FABP (relative expres-
sion, 7,058), an established liver-expressed FABP (22).
Because SREBP-1 is an important transcription factor
that can affect the expression of the highly upregulated
genes involved in lipogenesis (i.e., stearoyl-CoA dismutase-
1, PKLR, and ACLY), it was also determined whether
SREBP-1 protein expression was increased upon Western-
type diet feeding. Importantly, SREBP-1 is synthesized as
an inactive precursor protein (125 kDa), which has to
be cleaved into a smaller active mature SREBP-1 protein
(66 kDa) (26). Strikingly, in contrast to the observed in-
crease in SREBP-1 mRNA expression, a clear downregula-
tion of the mature SREBP-1 protein was determined upon
2weeks of atherogenic diet feeding in both the nuclear and
cytoplasmic fractions (Fig. 7). Quantification using Image-
Quant software revealed that nuclear mature SREBP-1 pro-
tein expression was decreased by 40% (n 5 2) on the
Western-type diet, whereas cytoplasmic protein expression
was decreased by 12% (n5 2). Themarked decrease in nu-
clear SREBP-1 protein expression indicates that SREBP-1
activity was decreased in liver parenchymal cells from LDL
receptor-deficient mice upon Western-type diet feeding.
DISCUSSION
The purpose of this study was to gain insight into the
response of the liver parenchymal cell, which is mainly
responsible for the liver’s metabolic function, to an in-
crease in dietary lipid levels in an atherosclerosis-prone
mouse model. More specifically, liver parenchymal cell
gene expression profiles in LDL receptor-deficient mice
on a Western-type (atherogenic) diet containing 0.25%
cholesterol and 15% fat for 2, 4, and 6 weeks were com-
pared with those of mice on a regular chow diet containing
4.3% fat and no cholesterol using microarray technology.
Based upon the microarray expression profiles, we pro-
pose that FABP5 and four putative novel FABP members
may play an essential role in the primary response of liver
parenchymal cells to an increase in dietary lipid levels, be-
cause their expression increases highly (.10-fold) within
the first 2 weeks of diet feeding, with a subsequent decline
Fig. 5. Biological process classes with a significantly (P , 0.05;
binomial test; PANTHER software) enhanced number of highly
regulated genes associated with the secondary response of liver
parenchymal cells to increased dietary lipid levels.
2204 Journal of Lipid Research Volume 47, 2006
 at W
alaeus Library / BIN 299, on Novem
ber 14, 2017
w
w
w
.jlr.org
D
ow
nloaded from
 
0.DC1.html 
http://www.jlr.org/content/suppl/2006/08/10/M600095-JLR20
Supplemental Material can be found at:
in the subsequent 2–4 weeks. The FABP family consists of
low-molecular-mass, soluble, intracellular lipid carriers
that bind fatty acid ligands with high affinity. Importantly,
deficiencies in or malfunctioning of FABPs have been
associated with the etiology of several lipid-related dis-
eases, such as diabetes, hyperlipidemia, and atherosclero-
sis, in both humans and animal disease models (27–31).
FABP1, also named liver FABP (L-FABP), is the key FABP
involved in the cellular uptake and metabolism of long-
chain fatty acids in the liver, and its expression is essential
for the peroxisomal b-oxidation of fatty acids (32–34). In
addition to fatty acids, FABP1 is also able to bind or inter-
act with a wide variety of other ligands, including anionic
cholesterol derivatives and bile acids (35, 36). However,
Western-type diet feeding did not affect gene expression
levels of FABP1 in liver parenchymal cells (data not
shown). FABP5, also named endothelial FABP (E-FABP),
functions as an antioxidant protein by scavenging reactive
lipids (i.e., fatty acids) such as 4-hydroxynonenal (37) and
leukotriene A4 (38). In addition, FABP5 also plays a role
in basal and hormone-stimulated lipolysis in adipose tis-
sue (39).
It thus seems that the expression of specific fatty acid
transporters in liver parenchymal cells ismarkedly changed
as a result of increased dietary lipid levels, thereby
potentially facilitating lipid uptake, transport, and metab-
olism. The fact that the expression of FABP5 and the
four novel FABP5-like transcripts is highly induced upon
Western-type diet feeding suggests that, in liver paren-
chymal cells, these proteins may play an important role in
protection against the cellular toxicity of reactive lipids
such as 4-hydroxynonenal and leukotriene A4, through
transporting them to intracellular compartments for sub-
sequentmetabolism.Because the fourputative FABPs share
homology with respect to their sequences, expression, and
regulationwith FABP5, it will be interesting to further study
the possible specific (shared?) functions of FABP5 and
thesenovel FABPs in liver. Interestingly,microarray analysis
by Maxwell et al. (7) revealed that FABP5 may be a novel
hepatic SREBP target gene, because its cholesterol diet-
induced regulation profile in total liver correlated with that
of other known SREBP target genes. ThemRNAexpression
of SREBP-1 was increased in liver parenchymal cells in
response to Western-type diet feeding. However, the cyto-
plasmic and nuclear expression of the mature (active)
SREBP-1 protein was decreased by 2 weeks of Western-type
diet feeding, indicating that the activity of SREBP-1 was
actually lower on the diet. The decrease inmature SREBP-1
Fig. 7. Effect of Western-type diet (WTD) feeding for 2 weeks on
the protein expression of mature SREBP-1 in liver parenchymal cell
nuclear (N) and cytoplasmic (C) fractions.
Fig. 6. Real-time quantitative PCR validation (closed circles) of the Western-type diet (WTD)-induced
changes in the expression of genes involved in the response of liver parenchymal cells to increased dietary
lipid levels in LDL receptor-deficient mice, as observed with microarray analysis (open circles). SREBP-1,
sterol-regulatory element binding protein-1.
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protein is likely attributable to extensive lipid loading, as
Wang et al. (26) have shown that cholesterol or oxysterol
loading of cells results in a rapid decay of mature SREBP-1
protein attributable to an impaired cleavage of the pre-
cursor protein. Althoughdata fromMaxwell et al. (26) have
suggested that FABP5 is a putative novel SREBP-1 target
gene, the z20-fold increase in parenchymal liver cell
FABP5 expression within the first 2 weeks on the Western-
type diet in this study was not caused by enhanced SREBP-1
activity. Loading of cells with fatty acids and cholesterol
(derivatives) has also been associated with changes in
the activity of other nuclear receptors, such as the liver
X receptor, the retinoic acid receptor, and peroxisome
proliferator-activated receptors (40–44). Therefore, it will
be interesting to study whether these and possibly other
nuclear receptors are involved in the regulation of the he-
patic expression of FABP5 and the novel FABPs.
In the secondary response of liver parenchymal cells to
theWestern-type diet, the expression of key genes involved
in lipogenesis pathways was markedly stimulated. More
specifically, in our study, a marked consistent upregula-
tion of genes involved in hepatic glucose metabolism [i.e.,
pyruvate kinase (45)] and subsequent pyruvate metabo-
lism and lipogenesis pathways [i.e., ACLY (46) and malic
enzyme (24)] was observed in isolated liver parenchymal
cells upon Western-type diet feeding, which suggests that
the Western-type diet as a secondary response induces
glycolytic and lipogenesis pathways. This is in agreement
with microarray data provided by de Fourmestraux et al.
(9) that indicate that high-fat diet feeding stimulates
glycolytic pathways in total liver. The apparent increase in
liver lipogenesis may also explain the observed increase in
serum VLDL cholesterol levels in LDL receptor-deficient
mice on the Western-type diet, because Grefhorst et al.
(47) have also shown that stimulation of lipogenesis
through pharmacological activation of the nuclear re-
ceptor liver X receptor leads to the production of large
triglyceride-rich VLDL particles. In accordance, LDL
receptor-deficient mice that have an increased hepatic
lipogenesis rate attributable to crossing with SREBP-1
transgenic mice accumulate large lipid-rich lipoproteins
(VLDLs) as a result of increased synthesis and secretion
and blocked degradation via the LDL receptor (48).
In conclusion, using a microarray-based approach, we
have identified FABP5 and four putative novel FABP5-like
FABPs as important genes involved in the primary re-
sponse of liver parenchymal cells from LDL receptor-
deficient mice to Western-type diet feeding, because they
may play an important role in the detoxification of
(specific) free fatty acids and/or lipid oxidants. Further-
more, as a secondary response, liver parenchymal cells
stimulate the glycolysis and lipogenesis pathways, resulting
in a subsequent increase in serum levels of the atherogenic
lipoproteins VLDL and LDL.
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